Tocilizumab in refractory giant cell arteritis. Monotherapy versus combined therapy with conventional immunosuppressive drugs. Observational multicenter study of 134 patients
- Calderón-Goercke, M.
- Castañeda, S.
- Aldasoro, V.
- Villa, I.
- Moriano, C.
- Romero-Yuste, S.
- Narváez, J.
- Gómez-Arango, C.
- Pérez-Pampín, E.
- Melero, R.
- Becerra-Fernández, E.
- Revenga, M.
- Álvarez-Rivas, N.
- Galisteo, C.
- Sivera, F.
- De Miguel, E.
- Prieto-Peña, D.
- González-Gay, M.Á.
- Hernández, J.L.
- Blanco, R.
ISSN: 1532-866X, 0049-0172
Year of publication: 2021
Volume: 51
Issue: 2
Pages: 387-394
Type: Article